- CA$10.45m
- CA$21.65m
- CA$48.80m
- 39
- 77
- 52
- 56
2019 April 30th | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 15.9 | 34.1 | 54.3 | 48.8 |
Cost of Revenue | |||||
Gross Profit | — | -1.31 | 0.025 | 9.48 | 9.85 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.123 | 24.1 | 57.1 | 85.1 | 61.6 |
Operating Profit | -0.123 | -8.24 | -23 | -30.8 | -12.8 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.123 | -28.5 | -0.164 | -26.1 | -9.46 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.123 | -28.7 | -0.664 | -24.9 | -10.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -0.123 | -28.7 | -17.8 | -189 | -9.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.123 | -28.7 | -17.8 | -189 | -9.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.551 | -9.14 | -0.661 | 7.33 | -0.71 |